SCFA Mediated Neuroprotection refers to the mechanism by which short-chain fatty acids (SCFAs), the metabolites produced by gut bacteria, confer a protective effect on the central nervous system. This neuroprotection involves reducing neuroinflammation, improving blood-brain barrier integrity, and modulating the function of microglia and astrocytes. This process highlights the critical role of the gut-brain axis in maintaining cognitive health and resilience.
Origin
This concept is a key finding in the emerging field of neuro-gastroenterology, specifically detailing the influence of the gut microbiome on brain health. The term combines the biochemical agents, SCFAs, with the biological effect, ‘neuroprotection,’ which is the prevention of neuronal damage. Research in germ-free animal models has been pivotal in establishing this link.
Mechanism
SCFAs, particularly butyrate, are transported across the blood-brain barrier where they act as histone deacetylase (HDAC) inhibitors, influencing gene expression in neurons and glial cells. They also bind to G-protein coupled receptors on microglia, modulating their inflammatory state and reducing the release of neurotoxic cytokines. This dual action supports neuronal plasticity and shields the brain from systemic inflammatory damage.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.